Experts are rapidly investigating retatrutide, a promising medication developed by Eli Lilly, as a significant breakthrough in physique reduction . Different than many earlier approaches, retatrutide is a double -action agonist targeting equally GLP-1 and GIP, hormones that influence appetite an